Cancer

Detect-ION and Moffitt Cancer Center Collaborate to Revolutionize Lung Cancer Early Detection

The pilot project partnership envisions breath diagnostics to be an in-home screening that is fast, inexpensive, and as easy as…

1 year ago

Safe Seated Mammography Using Enable Me’s VELA Mammography Chair Can Improve Image Clarity this World Breast Cancer Research Day Aug. 18

The clinically designed, technician friendly and FDA-approved VELA Mammography Chair is transforming women's typically uncomfortable and often painful standing mammography…

1 year ago

Genmab Announces Changes to its Executive Committee

Media Release COPENHAGEN, Denmark; August 16, 2024 Rayne Waller joins as Executive Vice President and Chief Technology OfficerBrad Bailey appointed…

1 year ago

AIM ImmunoTech Reports Second Quarter 2024 Financial Results and Provides Corporate Update

– Continued execution across Ampligen® clinical development programs and growing body of positive data in multiple high-value indications – Company…

1 year ago

Science in Space to Cure Disease on Earth–the International Space Station National Lab and NASA Announce New Funding Opportunity

Joint solicitation will award up to $4 million for biomedical R&D leveraging the orbiting laboratory KENNEDY SPACE CENTER, Fla., Aug.…

1 year ago

Mellie Appoints Two Industry Leaders to Its Advisory Board

SAN FRANCISCO, Aug. 15, 2024 /PRNewswire/ -- Mellie, an award-winning eldercare and special needs family caregiver support solution, announced the…

1 year ago

The American Journal of Gastroenterology Publishes Esopredict Performance Results from Pivotal Clinical Validation Study

Results demonstrate Esopredict's ability to predict the likelihood of progression to high-grade dysplasia or esophageal adenocarcinoma in patients with Barrett's…

1 year ago

Fractal Launches vaidya.ai, a Multimodal Health Assistant

NEW YORK, Aug. 15, 2024 /PRNewswire/ -- Fractal (www.fractal.ai), a global provider of artificial intelligence (AI) and advanced analytics solutions to…

1 year ago

CNS Pharmaceuticals Reports Second Quarter 2024 Financial Results

Potentially pivotal GBM study evaluating lead program, Berubicin, enrollment completed; Topline data expected in the first half of 2025Recent strategic…

1 year ago

CureVac Announces Financial Results for the Second Quarter and First Half of 2024 and Provides Business Update

Closed new licensing agreement with GSK worth up to €1.45 billion, including €400 million upfront; provides strong validation of CureVac's…

1 year ago